Plant-based hemostatic gel medical devices to stop bleeding
| Date | Round | Amount |
|---|---|---|
| Oct 2022 | Series A Brooklyn biotech Cresilon raised a $25M Series A-4 led by Paulson Investment Co. to expand production and enter the human-health market with its hemostatic gel. | $25M |